View Older Stories

Jun 27, 2026 02:40PM New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Jun 25, 2026 08:32AM Envoy Medical terminates $15M at-the-market equity facility

Jun 25, 2026 08:30AM Envoy Medical Terminates At-the-Market (ATM) Equity Facility

Jun 18, 2026 08:30AM Envoy Medical to Present at Investor Conferences on June 25th

Jun 12, 2026 02:45PM New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA

Jun 6, 2026 11:20AM New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET

Jun 4, 2026 08:30AM Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th

Jun 2, 2026 08:30AM Envoy Medical (NASDAQ:COCH) Signs Multi-Part Series With New to The Street

May 20, 2026 08:30AM Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology

May 11, 2026 08:02AM Envoy Medical completes enrollment for fully implanted cochlear trial

May 11, 2026 08:00AM Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant

Apr 28, 2026 08:35AM Envoy Medical shares six-month clinical data from cochlear implant study

Apr 28, 2026 08:30AM Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

Apr 22, 2026 08:00AM Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

Apr 16, 2026 08:02AM Envoy Medical adds Chas McKhann to board of directors

Apr 16, 2026 08:00AM Envoy Medical Appoints Chas McKhann to Board of Directors

Apr 1, 2026 08:04AM Envoy Medical first patients reach 12-month trial endpoint for implant

Apr 1, 2026 08:00AM Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant

Mar 31, 2026 06:25AM H.C. Wainwright Starts Envoy Medical (COCH) at Buy

Mar 23, 2026 08:30AM Envoy Medical Reports Full Year 2025 Financial Results

Mar 11, 2026 08:00AM Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant

Feb 24, 2026 08:02AM Envoy Medical regains Nasdaq compliance after meeting listing requirements

Feb 24, 2026 08:00AM Envoy Medical Regains Compliance with Nasdaq Listing Requirement

Feb 23, 2026 08:05AM Envoy Medical receives three new patents for hearing implant technology

Feb 23, 2026 08:00AM Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space

Feb 19, 2026 08:02AM Envoy Medical raises $30 million, nears clinical trial completion

Feb 19, 2026 08:00AM Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial

Feb 17, 2026 08:00AM Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

Feb 12, 2026 04:07PM Envoy Medical closes $78 million public offering with milestone warrants

Feb 12, 2026 04:05PM Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering

Feb 11, 2026 09:27AM Envoy Medical prices $78 million public offering with milestone warrants

Feb 11, 2026 09:25AM Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering

Dec 18, 2025 08:05AM Envoy Medical reaches midpoint enrollment in cochlear implant study

Dec 18, 2025 08:00AM Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

Dec 16, 2025 08:02AM Envoy Medical receives Australian patent for cochlear implant technology

Dec 16, 2025 08:00AM Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio

Dec 10, 2025 08:00AM Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant

Dec 4, 2025 08:00AM Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient

Dec 2, 2025 08:00AM Envoy Medical Announces the Grant of Its 40th U.S. Patent

Dec 1, 2025 04:34PM Envoy Medical (COCH) filed for 15.12M share offering by selling stockholders

Nov 20, 2025 08:00AM Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery

Nov 18, 2025 08:00AM Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial

Nov 10, 2025 08:00AM Envoy Medical Reports Third Quarter 2025 Financial and Operational Results

Nov 4, 2025 08:00AM Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial

Oct 29, 2025 08:00AM Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant

Oct 27, 2025 08:04AM Envoy Medical receives Nasdaq listing extension until February 2026

Oct 27, 2025 08:00AM Envoy Medical Receives Positive Listing Determination from NASDAQ

Oct 17, 2025 11:03AM Envoy Medical (COCH) files for 15.12M share offering by selling stockholders

Oct 9, 2025 04:07PM Envoy Medical closes $16 million registered direct offering

Oct 9, 2025 04:05PM Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

View Older Stories